Collegium Pharmaceutical Inc (COLL)
37.51
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
37.53
+0.02
(+0.05%)
After-Hours: 20:00
Collegium Pharmaceutical Price to Book Value: 6.134 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 6.134 |
| May 02, 2024 | 6.134 |
| May 01, 2024 | 6.178 |
| April 30, 2024 | 6.039 |
| April 29, 2024 | 6.003 |
| April 26, 2024 | 5.956 |
| April 25, 2024 | 5.861 |
| April 24, 2024 | 5.802 |
| April 23, 2024 | 5.877 |
| April 22, 2024 | 5.681 |
| April 19, 2024 | 5.698 |
| April 18, 2024 | 5.686 |
| April 17, 2024 | 5.797 |
| April 16, 2024 | 5.789 |
| April 15, 2024 | 5.747 |
| April 12, 2024 | 5.840 |
| April 11, 2024 | 5.951 |
| April 10, 2024 | 6.213 |
| April 09, 2024 | 6.344 |
| April 08, 2024 | 6.446 |
| April 05, 2024 | 6.540 |
| April 04, 2024 | 6.427 |
| April 03, 2024 | 6.452 |
| April 02, 2024 | 6.280 |
| April 01, 2024 | 6.358 |
| Date | Value |
|---|---|
| March 28, 2024 | 6.348 |
| March 27, 2024 | 6.690 |
| March 26, 2024 | 6.53 |
| March 25, 2024 | 6.568 |
| March 22, 2024 | 6.496 |
| March 21, 2024 | 6.486 |
| March 20, 2024 | 6.344 |
| March 19, 2024 | 6.208 |
| March 18, 2024 | 6.435 |
| March 15, 2024 | 6.393 |
| March 14, 2024 | 6.219 |
| March 13, 2024 | 6.263 |
| March 12, 2024 | 6.116 |
| March 11, 2024 | 6.133 |
| March 08, 2024 | 6.149 |
| March 07, 2024 | 6.084 |
| March 06, 2024 | 5.998 |
| March 05, 2024 | 5.938 |
| March 04, 2024 | 6.056 |
| March 01, 2024 | 6.072 |
| February 29, 2024 | 6.003 |
| February 28, 2024 | 5.980 |
| February 27, 2024 | 6.016 |
| February 26, 2024 | 5.979 |
| February 23, 2024 | 5.944 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.409
Minimum
Dec 01 2021
9.912
Maximum
Feb 07 2020
4.380
Average
4.219
Median
Jun 27 2023
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 4.473 |
| Immunogen Inc (DELISTED) | -- |
| AnaptysBio Inc | 8.074 |
| Recursion Pharmaceuticals Inc | 4.476 |
| Nuvalent Inc | 6.434 |
Price to Book Value Related Metrics
| PE Ratio | 31.52 |
| PS Ratio | 2.994 |
| Price to Free Cash Flow | 6.186 |
| Price | 37.51 |
| Earnings Yield | 3.17% |
| Market Cap | 1.199B |
| Operating PE Ratio | 10.16 |
| Normalized PE Ratio | 20.06 |